Fonterra (ASX:FSF) completes sale of DFE Pharma - Sequoia Direct Pty Ltd

23JanJanuary 23, 2020

Fonterra (ASX:FSF) completes sale of DFE Pharma

Fonterra (ASX:FSF) has completed the sale of its 50 per cent share of DFE Pharma to CVC Strategic Opportunities II.

Fonterra CFO, Marc Rivers, says the completion of this sale is a key milestone in strengthening the Coop’s balance sheet, with cash proceeds of $554 million, comprising of the original sale proceeds of $537 million plus $17 million in settlement adjustments.

Over the course of the 2020 financial year Fonterra expects there to be other one-off transactions as it implements strategy and continues its asset portfolio review.

Fonterra is a New Zealand multinational dairy co-operative owned by around 10,500 New Zealand farmers.

Shares in Fonterra (ASX:FSF) closed 0.8 per cent lower at $3.85 yesterday.

Copyright 2020 – Finance News Network

Source: Finance News Network

Related Posts

07OctOctober 7, 2019

A St Barbara JV collects quartz vein rock chip samples

07 Oct 2019 - A St Barbara (ASX:SBM) joint venture with advanced gold explorer Alice Queen ASX:AQX) has completed a soil and rock chip geochemical sampling program across its Horn Island project.

10MarMarch 10, 2020

West African Resources (ASX:WAF) processes first ore at Sanbrado Gold Project

10 Mar 2020 - Gold producer West African Resources, (ASX:WAF) is pleased to announce it has completed all construction activities and has started processing ore through the milling and CIL circuits at its Sanbrado Gold Project, Burkina Faso.

20AugAugust 20, 2020

The Qantas Group (ASX:QAN) profit nosedives 91%

20 Aug 2020 - In what has been the most challenging period in its long history, the Qantas Group (ASX:QAN) reported a $124 million Underlying Profit Before Tax for the 12 months ended 30 June 2020, down 91 per cent on the prior year.

23JunJune 23, 2020

Woolworths (ASX:WOW) profits to fall despite sales growth

23 Jun 2020 - Woolworths (ASX:WOW) released a trading update today showing expected earnings before interest and tax to fall between between $3.2 billion and $3.25 billion.

01JunJune 1, 2020

Mesoblast’s REMESTEMCEL-L “significantly improved outcomes” in patients with inflammatory lung disease and COVID-19

01 Jun 2020 - Mesoblast (ASX:MSB) says its lead mesenchymal stem cell (MSC) product candidate remestemce-L treatment showed significantly improved outcomes for patients with chronic obstructive pulmonary disease (COPD).

23OctOctober 23, 2019

Netlinkz (ASX:NET) enters into an agreement to acquire SSI Pacific

23 Oct 2019 - Netlinkz (ASX:NET) has entered into an agreement to acquire Security Software International (SSI) Pacific.

09JulJuly 9, 2020

Worley (ASX:WOR) increases stake in TW Power Services

09 Jul 2020 - Worley (ASX:WOR) has acquired Ferrovial’s 50 per cent shareholding of TW Power Services for a cash consideration of $20 million, increasing its stake to 100 per cent.

24DecDecember 24, 2020

Cimic Group (ASX:CIM) finalizes 50% sale of Theiss

24 Dec 2020 - Cimic Group (ASX:CIM) has now signed relevant material documentation including financing agreements for the sale of 50 per cent of Thiess, the world’s largest mining services provider.

24FebFebruary 24, 2021

Cochlear (ASX:COH) receive FDA approval for the Baha sound processor

24 Feb 2021 - Hearing solutions company Cochlear (ASX:COH) has received US Food and Drug Administration (FDA) clearance and CE Mark accreditation for the new Cochlear Baha 6 Max Sound Processor.

24DecDecember 24, 2019

360 Capital Group (ASX:TGP) and 360 Capital Total Return (ASX:TOT) take 19.99% stake in Velocity

24 Dec 2019 - 360 Capital Group (ASX:TGP) and 360 Capital Total Return (ASX:TOT) via their JV investment company TGP TOT JV have taken a 19.99 per cent cornerstone equity stake in Velocity Property Group Limited (ASX:VP7).